American Society of Hirudotherapy

Positive Effect of Wrapping with Nerve Conduit on Nerve Recovery after Peripheral Nerve Suturing

Research article published in Plastic and reconstructive surgery (2025)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Clinical TrialsMiyashima et al. · Plastic and reconstructive surgery, 2025

Abstract

BACKGROUND: Complete recovery after end-to-end peripheral nerve suturing remains challenging due to perineural scarring. The authors developed a biodegradable nerve conduit composed of polylactide (PLA) and polycaprolactone (PCL) to prevent adhesion and promote nerve regeneration. This study assessed whether wrapping a sutured nerve with this conduit could reduce adhesion and enhance recovery in a rat model. METHODS: Thirty-six rats underwent sciatic nerve transection, suturing, and adhesion induction, and were assigned to a control group (no wrapping) or a wrapping group (PLA/PCL conduit). At 12 weeks, functional recovery was assessed using the von Frey test, sciatic functional index, and gastrocnemius muscle weight. Electrophysiologic assessments included compound muscle action potential amplitude and nerve conduction velocity. Histologic analyses were performed to evaluate axonal regeneration, perineural scarring, and fascicular morphology. Fascicular circularity was analyzed for correlation with electrophysiologic outcomes. RESULTS: The wrapping group showed significantly better sensory and motor recovery, with higher compound muscle action potential amplitude and nerve conduction velocity. Histologic examination revealed enhanced axonal regeneration, reduced perineural scarring, and preservation of fascicular circularity. Fascicular circularity was positively correlated with electrophysiologic performance. CONCLUSIONS: The PLA/PCL conduit effectively minimized perineural scar adhesion and nerve compression while promoting nerve regeneration and functional recovery during the first 12 weeks. Its tubular structure maintained integrity, preventing scar invasion and preserving fascicular morphology. Although these findings highlight the short-term potential of the PLA/PCL conduit for peripheral nerve repair, further studies are warranted to evaluate its long-term safety and efficacy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsRatsNerve RegenerationPolyestersRecovery of FunctionSciatic NerveSuture TechniquesRats, Sprague-DawleyDisease Models, AnimalMaleNerve Conduction StudiesPeripheral Nerve Injuries

Summary

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

In a rat sciatic-nerve model (36 animals), this study tested whether wrapping a sutured nerve in a biodegradable polylactide/polycaprolactone (PLA/PCL) conduit reduces perineural scar adhesion versus no wrapping, and at 12 weeks reported significantly better sensory and motor recovery, higher compound muscle action potential amplitude and nerve conduction velocity, enhanced axonal regeneration, and reduced scarring in the wrapped group. Its connection to hirudotherapy is indirect: nerve repair and peripheral neuropathy fall within the reconstructive and pain-management contexts where leech therapy is sometimes explored for its local anti-inflammatory and microcirculatory effects, and the paper highlights perineural scarring and adhesion as a key barrier to recovery. Honest caveat: this is a preclinical animal study of a synthetic conduit, not a leech intervention, the authors themselves note only short-term (12-week) data and call for further long-term safety and efficacy work, so it does not support any clinical claim for hirudotherapy.

Citation

Positive Effect of Wrapping with Nerve Conduit on Nerve Recovery after Peripheral Nerve Suturing.

Miyashima et al. · Plastic and reconstructive surgery, 2025

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.